Clinical Impact Costs and Costeffectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts

Simple item page
dc.citation.doi10.1093/CID/CIAA1418
dc.citation.epage2917
dc.citation.spage2908
dc.contributor.authorAnne M Neilan
dc.contributor.authorElena Losina
dc.contributor.authorAudrey C Bangs
dc.contributor.authorClare Flanagan
dc.contributor.authorA Et Al
dc.contributor.authorGuy Harling
dc.date.accessioned2023-04-17T13:45:02Z
dc.date.available2023-04-17T13:45:02Z
dc.identifier.citationWOS
dc.identifier.issn1058-4838
dc.identifier.urihttps://hdl.handle.net/10539/35237
dc.journal.titleCLINICAL INFECTIOUS DISEASES
dc.journal.volume73
dc.titleClinical Impact Costs and Costeffectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal.pdf
Size:
376.4 KB
Format:
Adobe Portable Document Format
Description:
Journal
Download
Collections
Centre for Health Policy